WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC

Clinical trial NCT05351320 · UNKNOWN

Trial details

NCT number: NCT05351320
Sponsor: Jinming Yu
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2022-04-30
Primary completion: 2026-04-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.